Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
Bengaluru, India (ots/PRNewswire) - Leveraging Infosys Cobalt to deliver industry-leading infrastructure-managed services Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a multi-year strategic collaboration with First Abu Dhabi Bank ...
Bengaluru, India (ots/PRNewswire) - FY25 guidance - revenue growth of 1%-3% and operating margin of 20%-22% Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered $18.6 billion in FY24 revenues with a growth of 1.4% in constant currency and ...
Zurich (ots/PRNewswire) - - On behalf of its client Matter Labs, Sygnum is investing USD 50m into Fidelity's Institutional Liquidity Fund (ILF) - Sygnum generates on-chain representation by issuing security tokens that act as secure and transparent "Proof-of-Reserves" for Matter Labs' treasury reserves - Represents first step in Matter Labs' long-term strategy to move ...
Social Acceptance of Immigrants Working as Politicians or Judges Is Low Often, the dominant society develops negative attitudes towards immigrants and their descendants because their integration is too successful – and not, because they are unwilling to integrate. This is the finding of a new study, conducted by researchers of the University of Mannheim and ...
Bengaluru, India (ots/PRNewswire) - Infosys Topaz driving strong differentiation and market leadership in generative AI Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered $4,663 million in Q3 revenues with year-on-year and sequential decline of ...
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
NTT DATA Business Solutions AG
Bengaluru, India (ots/PRNewswire) - Q2 growth at 2.3% sequentially with resilient margins of 21.2%. Revenue guidance revised to 1.0%- 2.5% Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered $4,718 million in Q2 revenues with year-on-year growth ...
